Vytrus Biotech, S.A. (BME:VYT)

Market Cap	31.07M
Revenue (ttm)	5.24M
Net Income (ttm)	696.78K
Shares Out	7.54M
EPS (ttm)	0.09
PE Ratio	44.59
Forward PE	29.94
Dividend	n/a
Ex-Dividend Date	n/a

Volume	219
Average Volume	7,262
Open	4.120
Previous Close	4.080
Day's Range	4.120 - 4.120
52-Week Range	2.100 - 4.120
Beta	0.11
RSI	74.97
Earnings Date	n/a

About Vytrus Biotech

Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells for the cosmetic sector primarily in Spain. It offers Nectaria Lithops, an active ingredient that biophysically optimizes the skin microenvironment and vitamin D levels; Photobiome a microbiota photoprotector; Olea Vitae cellular oil for ageing; Turmeria Zen for skin hydration and wrinkles on stressed profiles; Sensia Carota, a plant-based active that protects and prevents from the damage on sensitive and sensitized skins; Deobiome Noni, a biological deo...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Employees: 35
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: VYT

Financial Performance

In 2023, Vytrus Biotech's revenue was 4.70 million, an increase of 4.90% compared to the previous year's 4.48 million. Earnings were 544,944, a decrease of -9.97%.